Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chandra Bhagat Pharma Limited has informed BSE that corporate governance compliance is not applicable to the company for the quarter ended 30 September 2025. The company states this exemption is available under Regulation 15 of SEBI (LODR) Regulations 2015 because it is listed on the SME Exchange. As a result, the company is not required to submit a quarterly Corporate Governance Report for Q2 FY26. The filing was signed by Rajni Dawani, Company Secretary & Compliance Officer.
This is a routine regulatory disclosure with no material impact on shareholders or stock price. It simply confirms the company's SME-listed status, which exempts it from certain corporate governance reporting obligations.